D. Narayanan

Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches.

Richard A. Engh, Dilip Narayanan, Osman A. B. S. M. Gani, 2015, Biochimica et biophysica acta.

Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery.

M. Sattler, S. Meier, C. Softley, 2020, Journal of Medicinal Chemistry.

Evaluating the Predictivity of Virtual Screening for Abl Kinase Inhibitors to Hinder Drug Resistance

Osman A. B. S. M. Gani, R. Engh, D. Narayanan, 2013, Chemical biology & drug design.

Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery.

G. Popowicz, M. Sattler, M. Gajhede, 2022, Journal of medicinal chemistry.

Targeting the Redox Landscape in Cancer Therapy

D. Narayanan, D. Özcelik, Sana Ma, 2020, Cancers.

Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR

Richard A. Engh, Dilip Narayanan, Osman A. B. S. M. Gani, 2017, Journal of Cheminformatics.

Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds.

G. Popowicz, M. Sattler, M. Gajhede, 2021, Journal of medicinal chemistry.

A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.

Alejandro Aguayo-Orozco, Dilip Narayanan, A. Bach, 2019, Journal of medicinal chemistry.

Small-molecule modulators of tumor necrosis factor signaling.

M. Gajhede, A. Bach, C. Gotfredsen, 2023, Drug discovery today.